Evidence map›Paper›PMID 18617645›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2008

Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults.

Alexander M Strasak, Cecily C Kelleher, Jochen Klenk, Larry J Brant, Elfriede Ruttmann, Kilian Rapp, Hans Concin, Günter Diem, Karl P Pfeiffer, Hanno Ulmer and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Liver enzymes and risk of ocular motor cranial nerve palsy: a nationwide population-based study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Alexander M StrasakDepartment of Medical Statistics, Innsbruck Medical University, Innsbruck, Austria.
Cecily C Kelleher
Jochen Klenk
Larry J Brant
Elfriede Ruttmann
Kilian Rapp
Hans Concin
Günter Diem
Karl P Pfeiffer
Hanno Ulmer
Vorarlberg Health Monitoring and Promotion Program Study Group
Innsbruck Medical University · ATNational Institute on Aging · USUniversität Ulm · DEUniversity College Dublin · IE

Funding

Gender Differences And Individual Variability In Human AgingZICAG000637 · NIA · NATIONAL INSTITUTE ON AGING · PI BRANT, LARRY · 2009 to 2011
$343k
HEALTH PROMOTION, MODIFIABLE RISK FACTORS AND AGINGZ01AG000638 · NIA · NATIONAL INSTITUTE ON AGING · PI BRANT, LARRY · 1990 to 2008
$172k
Intramural NIH HHS Z01 AG000638
6 · The paper itself

Abstract

objectiveThe purpose of this study was to investigate the association of longitudinal change in serum gamma-glutamyltransferase (GGT) with mortality from cardiovascular disease (CVD). METHODS AND

resultsA population-based cohort of 76,113 Austrian men and women with 455,331 serial GGT measurements was prospectively followed-up for a median of 10.2 years after assessment of longitudinal GGT change during an average period of 6.9 years. Cox proportional hazards regression with time-varying covariates was used to evaluate GGT change as an independent predictor for CVD death. Independently of baseline GGT and other classical CVD risk factors, a pronounced increase in GGT (7-year change >9.2 U/L) was significantly associated with increased total CVD mortality in men (P=0.005); the adjusted hazard ratio (95% confidence interval) in comparison to stable GGT (7-year change -0.7 to 1.3 U/L) was 1.40 (1.09 to 1.81). Similarly, total CVD risk was elevated for increasing GGT in women, although effects were less pronounced and statistically significant only in subanalyses regarding coronary heart disease. Age of participants significantly modified the relation between GGT change and CVD mortality, with markedly stronger associations to be observable for younger individuals.

conclusionsOur study is the first to demonstrate that a longitudinal increase in GGT, independently of baseline GGT and even within its normal range, significantly increases risk of fatal CVD.

Indexed as

AdultAgedAged, 80 and overAge FactorsAustriaBiomarkersCardiovascular DiseasesFemalegamma-GlutamyltransferaseHumansLongitudinal StudiesMaleMiddle AgedPopulation SurveillanceProportional Hazards ModelsProspective StudiesBiomarkersgamma-Glutamyltransferase

Identifiers

PMID18617645
PMCPMC2643843
OpenAlexW2121106110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.